4//SEC Filing
Lucas Svetlana 4
Accession 0001209191-19-040458
CIK 0001339970other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:16 PM ET
Size
5.8 KB
Accession
0001209191-19-040458
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Lucas Svetlana
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-28+2,285→ 2,285 totalExercise: $5.13Exp: 2029-06-28→ Common Stock (2,285 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors.
- [F2]The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001781292
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:16 PM ET
- Size
- 5.8 KB